SLS Bio General Subscription Competition Rate 345 to 1... Subscription Deposit 233.1 Billion Won

SLS Bio, which is pursuing a transfer listing from KONEX to KOSDAQ, announced on the 11th that the public offering subscription for general investors recorded a competition rate of 345.96 to 1 and subscription deposits of approximately 233.1 billion KRW.

Founded in 2007, SLS Bio is a company that develops and sells in vitro diagnostic devices for humans and animals. It was listed on the KONEX market in 2016 and plans to transfer list to the KOSDAQ market on the 20th. The lead underwriter is Hana Securities. Until the 22nd of last month, a demand forecast was conducted for institutional investors, and the public offering price was set at 7,000 KRW, below the lower end of the expected range (8,200 to 9,400 KRW).

SLS Bio stated that the funds raised through the listing will be invested in production facilities and used to expand into regions such as the Middle East and North Africa in cooperation with international organizations like the United Nations.